Recent Blog Articles
Harvard Health Ad Watch: An IV treatment for thyroid eye disease
Taking up adaptive sports
Cutting and self-harm: Why it happens and what to do
Discrimination at work is linked to high blood pressure
Pouring from an empty cup? Three ways to refill emotionally
Give praise to the elbow: A bending, twisting marvel
Sneezy and dopey? Seasonal allergies and your brain
The FDA relaxes restrictions on blood donation
Apps to accelerometers: Can technology improve mental health in older adults?
Swimming and skin: What to know if a child has eczema
Mark Benson, MD, PhD
Contributor
Mark D. Benson, M.D., Ph.D. is the Director of Preventive Cardiology at Beth Israel Deaconess Medical Center (BIDMC). He is also a basic and translational researcher in the field.
Dr. Benson received his B.A. in biological sciences from Columbia University and his M.D. and Ph.D. in pharmacology from the University of Michigan. He completed his residency training in internal medicine at the University of Michigan, his fellowship training in cardiology at Brigham and Women’s Hospital, and his post-doctoral training in multi-omics research at BIDMC.
Dr. Benson is a principal investigator at the CardioVascular Institute at BIDMC. His laboratory’s interests are focused on applying emerging metabolomics, proteomics, and genomics technologies to detect signatures of small molecules in blood that may be used to predict an individual’s future risk of developing cardiovascular disease. The ultimate goal of this research is to identify novel biomarkers and pharmacological targets that may improve preventive cardiovascular disease therapy.
